148 related articles for article (PubMed ID: 12871480)
1. Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia.
Hoffman R; Eliakim R; Zuckerman T; Rowe JM; Brenner B
J Thromb Haemost; 2003 Mar; 1(3):606-8. PubMed ID: 12871480
[No Abstract] [Full Text] [Related]
2. Immediate haemostasis with recombinant factor VIIa for haemorrhage following Hickman line insertion in acute myeloid leukaemia.
Osborne W; Bhandari S; Tait RC; Franklin IM
Clin Lab Haematol; 2004 Jun; 26(3):229-31. PubMed ID: 15163323
[TBL] [Abstract][Full Text] [Related]
3. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
Poon MC
Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia.
Zver S; Andoljsek D; Cernelc P
Eur J Haematol; 2004 Jun; 72(6):455-6. PubMed ID: 15128428
[No Abstract] [Full Text] [Related]
5. Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven).
Zülfikar B; Kayiran SM
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):261-3. PubMed ID: 15060424
[TBL] [Abstract][Full Text] [Related]
6. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
[TBL] [Abstract][Full Text] [Related]
7. More on: Platelet count and the use of recombinant factor VIIa for the treatment of bleeding complications after hematopoietic stem cell transplantation.
Marietta M; Facchini L; Girardis M; Luppi M; Torelli G
J Thromb Haemost; 2006 Jan; 4(1):288. PubMed ID: 16409495
[No Abstract] [Full Text] [Related]
8. Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding.
Mantzios G; Tsirigotis P; Pappa V; Spirou K; Giannopoulou V; Kaitsa I; Girkas K; Papageorgiou E; Dervenoulas J
Eur J Haematol; 2007 Feb; 78(2):173-4. PubMed ID: 17313564
[No Abstract] [Full Text] [Related]
9. Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?
Kessler C
Intensive Care Med; 2002 Oct; 28 Suppl 2():S228-34. PubMed ID: 12404091
[TBL] [Abstract][Full Text] [Related]
10. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
Laurian Y
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():37-40. PubMed ID: 12214146
[TBL] [Abstract][Full Text] [Related]
11. Recombinant activated factor VII (NovoSeven) stops severe intra-abdominal bleeding after liver needle biopsy without surgery.
Sendensky A; Gutzwiller JP; Schneider-Frost J; Wuillemin WA; Graeni R; Beglinger C
Blood Coagul Fibrinolysis; 2004 Oct; 15(8):701-2. PubMed ID: 15613927
[No Abstract] [Full Text] [Related]
12. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
13. Successful use of recombinant factor VIIa in pelvic fracture haemorrhage.
Dhruva KK; Joel VD; Antony S; Vinodan K
J Indian Med Assoc; 2006 Jan; 104(1):42, 44. PubMed ID: 16850866
[TBL] [Abstract][Full Text] [Related]
14. The use of recombinant factor VIIa in a patient with essential thrombocythaemia with uncontrolled surgical bleeding.
Cervera JS; Mena-Durán AV; Piqueras CS
Thromb Haemost; 2005 Feb; 93(2):383-4. PubMed ID: 15711760
[No Abstract] [Full Text] [Related]
15. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
[No Abstract] [Full Text] [Related]
16. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
Shamsi T; Tufail M; Aftab M; Ansari S
J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
[TBL] [Abstract][Full Text] [Related]
17. Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
Blatt J; Gold SH; Wiley JM; Monahan PE; Cooper HC; Harvey D
Bone Marrow Transplant; 2001 Aug; 28(4):405-7. PubMed ID: 11571515
[TBL] [Abstract][Full Text] [Related]
18. Antidotes to haemorrhage: recombinant factor VIIa.
Kessler CM
Best Pract Res Clin Haematol; 2004 Mar; 17(1):183-97. PubMed ID: 15171966
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of recombinant factor VIIa in the treatment of bleeding episodes in patients with aplastic anemia.
Al Hammadi AM; Sallah S
J Thromb Haemost; 2007 Feb; 5(2):435-6. PubMed ID: 17269940
[No Abstract] [Full Text] [Related]
20. Successful treatment of massive acute upper gastrointestinal bleeding in liver failure with activated recombinant factor VII (NovoSeven): a case report.
Tonkic A; Jukic I; Titlic M; Mise S
Blood Coagul Fibrinolysis; 2005 Jul; 16(5):385-7. PubMed ID: 15970725
[No Abstract] [Full Text] [Related]
[Next] [New Search]
